Prognosis
Russia Approves Second Covid-19 Vaccine Before Phase 3 Trial
- Former bio-weapons lab’s vaccine was registered for public use
- Race for inoculation gains urgency amid record Russian cases
Photographer: Andrey Rudakov/Bloomberg
This article is for subscribers only.
Russian health authorities approved a Covid-19 vaccine created by a former biological weapons research laboratory for public use, marking the second time the Kremlin has bypassed accepted scientific protocol as it tries to field a defense against the pandemic.
A vaccine developed by the Vector State Virology and Biotechnology Center in Siberia has been registered, President Vladimir Putin said in televised comments Wednesday.